Yes, they seem to getting closer to profitability, but not quite there yet. The company has had FDA approval for 7+ years, but becoming profitable has been like turning around a battleship in a bathtub. The new features of the system and the changing business model have consumed some of their cash, but it should pay off in the long run. Hopefully not too much longer though! They stopped predicting breakeven or profitability many quarters ago, and they don't seem to be in a hurry to get there. 'Breaking even' financially will probably be the next catalyst that will drive the stock price. As long as they don't run out of cash before then, I'll hang in there.
I would be thrilled with those numbers, but they might be too optimistic. Mgmt seems to be spending a lot of $$ on SG&A, but the number of at home patients seems to be stuck at 5K-6K. Not sure they're getting much bang for their buck there, but hopefully the new features (nocturnal, high flow, etc) will help. I think they could be profitable now, but with their spending habits, it might take a while longer than your one year window.